ʻO ke Belt and Road: Ka Launa Pū, ka Lokahi a me ka Lanakila-Lanakila
nā huahana

Nutraceutical

  • ʻO Exenatide CAS:141732-76-5

    ʻO Exenatide CAS:141732-76-5

    He lāʻau lapaʻau ʻo Exenatide i hoʻohana ʻia no ka mālama ʻana i ka maʻi diabetes type 2. No loko ia o kahi papa o nā lāʻau i kapa ʻia ʻo glucagon-like peptide-1 (GLP-1) receptor agonists, e kōkua ana i ka hoʻohaʻahaʻa ʻana i nā pae kō koko ma o ka hoʻonui ʻana i ka huna ʻana o ka insulin a me ka hōʻemi ʻana i ka hoʻokuʻu ʻana o ka glucagon ma hope o ka ʻai ʻana. Hoʻokele ʻia ʻo Exenatide ma o ka inikini subcutaneous a ua kuhikuhi pinepine ʻia ma ke ʻano he mea hoʻohui i ka ʻai a me ka hoʻoikaika kino e hoʻomaikaʻi i ka kaohi glycemic i nā poʻe maʻi me ka maʻi diabetes type 2.

  • ʻO Tirzepatide CAS:2023788-19-2

    ʻO Tirzepatide CAS:2023788-19-2

    ʻO Tirzepatide kahi agonist receptor polypeptide (GIP) insulinotropic polypeptide (GIP) a me glucagon-like peptide-1 (GLP-1) e pili ana i ka glucose i hoʻohana ʻia i ka mālama ʻana i ka maʻi diabetes type 2. Hana ia e hoʻoponopono i nā pae kō koko ma o ka hoʻoulu ʻana i ka hoʻokuʻu ʻana o ka insulin a me ka pale ʻana i ka hoʻokuʻu ʻana o ka glucagon, e hoʻomaikaʻi ana i ka kaohi glycemic holoʻokoʻa. Hoʻokele ʻia ʻo Tirzepatide ma o ka inikini subcutaneous a kuhikuhi pinepine ʻia me nā hoʻololi ʻana i ke ʻano o ka nohona e kōkua i nā poʻe maʻi me ka maʻi diabetes type 2 e hoʻokō i ka kaohi maikaʻi ʻana o ko lākou pae kō koko.

  • ʻO Thymopentin CAS:69558-55-0

    ʻO Thymopentin CAS:69558-55-0

    He peptide immunomodulatory ka Thymopentin e hana ana ma ka ʻōnaehana pale ma ke hoʻohālike ʻana i kahi ʻāpana o ke kaʻina o thymosin. Kōkua ia i ka hoʻoponopono ʻana i ka hana T lymphocyte a paipai i ka pane pale.

  • ʻO Pramlintide CAS: 151126-32-8

    ʻO Pramlintide CAS: 151126-32-8

    He ʻano hana ʻia ʻo Pramlintide o ka amylin, kahi hormone i hoʻokuʻu ʻia e ka pancreas me ka insulin e kōkua i ka hoʻoponopono ʻana i nā pae kō koko. Hoʻohana ʻia ia me ka lāʻau lapaʻau insulin e hoʻomaikaʻi i ka kaohi ʻana i ke kō koko i nā poʻe maʻi me ka maʻi diabetes type 1 a i ʻole type 2.

  • ʻO Lixisenatide CAS:320367-13-3

    ʻO Lixisenatide CAS:320367-13-3

    He agonist receptor glucagon-like peptide-1 (GLP-1) ʻo Lixisenatide i hoʻohana ʻia e hoʻokele i nā pae kō koko i nā poʻe maʻi me ka maʻi diabetes type 2. Hana ia ma ka hoʻoulu ʻana i ka huna ʻana o ka insulin a me ka pale ʻana i ka hoʻokuʻu ʻana o ka glucagon, e alakaʻi ana i ka hoʻomaikaʻi ʻana i ka kaohi glucose. Hoʻokele ʻia ʻo Lixisenatide ma o ka inikini subcutaneous i hoʻokahi manawa i ka lā a kuhikuhi pinepine ʻia me ka ʻai a me ka hoʻoikaika kino e hoʻokō i ka hoʻokele glycemic maikaʻi aʻe.

  • ʻO Octreotide CAS:79517-01-4

    ʻO Octreotide CAS:79517-01-4

    ʻO Octreotide kahi mea like me ka somatostatin e kāohi ana i ka hoʻokuʻu ʻia ʻana o nā hormones he nui ma ke ʻano like me nā hopena o ka somatostatin kūlohelohe no ka mālama ʻana i nā maʻi neuroendocrine a me nā maʻi endocrine pili.

  • ʻO Liraglutide CAS:204656-20-2

    ʻO Liraglutide CAS:204656-20-2

    He agonist receptor GLP-1 ʻo Liraglutide i hoʻohana ʻia e mālama i ka maʻi diabetes type 2 a me ka momona. Hoʻohālike ia i ka hana a GLP-1 ma ka hoʻolaha ʻana i ka hoʻokuʻu ʻana o ka insulin a me ke kāohi ʻana i ka hoʻokuʻu ʻana o ka glucagon, e kōkua ana i ka hoʻohaʻahaʻa ʻana i nā pae kō koko a me ke kaumaha.

  • ʻO Teduglutide CAS:197922-42-2

    ʻO Teduglutide CAS:197922-42-2

    He lāʻau lapaʻau ʻo Teduglutide i hoʻohana ʻia e mālama i ka short bowel syndrome (SBS), kahi maʻi kakaikahi e hiki ke kū ma hope o ka wehe ʻana i kahi ʻāpana o ka ʻōpū liʻiliʻi. He ʻano synthetic kēia lāʻau lapaʻau o kahi hormone kūlohelohe i kapa ʻia ʻo glucagon-like peptide-2 (GLP-2), e kōkua ana i ka hoʻomaikaʻi ʻana i ka omo ʻana o ka ʻōpū a hoʻemi i ka pono no ka meaʻai parenteral i nā poʻe maʻi me SBS.

  • Pasireotide CAS:396091-73-9

    Pasireotide CAS:396091-73-9

    He lāʻau lapaʻau i hoʻolālā ʻia no nā mea he nui ka receptor i hoʻohana ʻia e mālama i nā ʻano maʻi endocrine kikoʻī a me nā maʻi pili ma o ka pale ʻana i ka hana o nā mea loaʻa o ka hormone ulu lehulehu a me nā mea loaʻa o ka insulin-like growth factor.

  • ʻO Mifamurtide CAS:83461-56-7

    ʻO Mifamurtide CAS:83461-56-7

    He immunomodulator ʻo Mifamurtide e hana ana ma ke ʻano he lāʻau lipopolysaccharide e hakakā ai i nā ʻōpū ma o ka hoʻohālike ʻana a me ka hoʻoikaika ʻana i ka pane pale o ka mea hoʻokipa.

  • ʻAlabiglutide CAS:82500-75-8

    ʻAlabiglutide CAS:82500-75-8

    He agonist receptor GLP-1 ʻo Albiglutide i hoʻohana ʻia e mālama i ka maʻi diabetes type 2. Hoʻohālike ia i ka hana a GLP-1 e hoʻolaha i ka hoʻokuʻu ʻana o ka insulin a kāohi i ka hoʻokuʻu ʻana o ka glucagon, e kōkua ana i ka kaohi ʻana i nā pae kō koko.

  • ʻO Somatostatin CAS:51110-01-1

    ʻO Somatostatin CAS:51110-01-1

    ʻO Somatostatin kahi hormone multifunctional e hoʻoponopono i nā pae hormone a me ka neurotransmission i loko o ke kino ma ka pale ʻana i ka hoʻokuʻu ʻana o nā endocrine a me nā neurotransmitters he nui.